• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶 7 是系统性硬皮病相关间质性肺病的候选生物标志物。

Matrix metalloproteinase 7 is a candidate biomarker in systemic sclerosis-associated interstitial lung disease.

出版信息

Acta Reumatol Port. 2020 Jul-Sep;45(3):191-200.

PMID:33139675
Abstract

BACKGROUND

Pulmonary complications, including pulmonary fibrosis, are the leading causes of death in systemic sclerosis(SSc). However, the aetiology and pathophysiologic mechanisms of the disease have not been comprehensively investigated, and drugs for treating systemic sclerosis-associated interstitial lung disease (SSc-ILD) are limited. The objective of this study was to identify key novel genes and pathways linked to SSc-ILD and decipher the molecular mechanisms involved in the disease.

METHODS

We compared three microarray datasets in the GEO database including 42 SSc-ILD samples and 18 normal samples to obtain differentially expressed genes (DEGs). Gene Ontology (GO) analysis and the Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway analysis were performed, and a protein-protein interaction network was constructed. After validation, gene set enrichment analysis (GSEA) was applied to obtain further insights into the function of the selected hub genes.

RESULTS

A total of 25 DEGs were filtered. The GO analysis revealed genes that were mainly enriched in immune response, chemokine activity, and extracellular regions. KEGG pathway analysis of the DEGs revealed that SSc-ILD was associated with the tumour necrosis factor (TNF) signalling pathway and cytokine-cytokine receptor interaction. Matrix metallopeptidase 7 (MMP7) expression was consistently increased in all the three datasets, and results of the GSEA indicated that MMP7 might play a role in the regulation of the G-protein coupled amine receptor activity.

CONCLUSIONS

In summary, the novel DEGs, especially MMP7 and the SSc-ILD pathway genes identified in this study might provide further insights into potential molecular mechanism of the disease.

摘要

背景

肺并发症,包括肺纤维化,是系统性硬皮病(SSc)死亡的主要原因。然而,该疾病的病因和病理生理机制尚未得到全面研究,且治疗系统性硬皮病相关间质性肺病(SSc-ILD)的药物有限。本研究旨在确定与 SSc-ILD 相关的关键新基因和途径,并阐明疾病涉及的分子机制。

方法

我们比较了 GEO 数据库中的三个微阵列数据集,包括 42 个 SSc-ILD 样本和 18 个正常样本,以获得差异表达基因(DEGs)。进行基因本体论(GO)分析和京都基因与基因组百科全书(KEGG)途径分析,并构建蛋白质-蛋白质相互作用网络。验证后,进行基因集富集分析(GSEA),以进一步了解所选枢纽基因的功能。

结果

共筛选出 25 个 DEG。GO 分析表明,这些基因主要富集在免疫反应、趋化因子活性和细胞外区。DEGs 的 KEGG 途径分析表明,SSc-ILD 与肿瘤坏死因子(TNF)信号通路和细胞因子-细胞因子受体相互作用有关。基质金属蛋白酶 7(MMP7)在所有三个数据集均持续上调,且 GSEA 结果表明,MMP7 可能在 G 蛋白偶联胺受体活性的调节中发挥作用。

结论

总之,本研究中鉴定的新 DEG,尤其是 MMP7 和 SSc-ILD 途径基因,可能为该疾病的潜在分子机制提供进一步的见解。

相似文献

1
Matrix metalloproteinase 7 is a candidate biomarker in systemic sclerosis-associated interstitial lung disease.基质金属蛋白酶 7 是系统性硬皮病相关间质性肺病的候选生物标志物。
Acta Reumatol Port. 2020 Jul-Sep;45(3):191-200.
2
Integrative analysis of lung molecular signatures reveals key drivers of systemic sclerosis-associated interstitial lung disease.肺分子特征的综合分析揭示了系统性硬皮病相关间质性肺病的关键驱动因素。
Ann Rheum Dis. 2022 Jan;81(1):108-116. doi: 10.1136/annrheumdis-2021-220493. Epub 2021 Aug 11.
3
Detection and Characterization of microRNAs and Their Target Genes in microRNA Microarray Datasets from Patients with Systemic Sclerosis-Interstitial Lung Disease.系统性硬皮病-间质性肺病患者 miRNA 芯片数据集中小 miRNA 及其靶基因的检测和鉴定。
DNA Cell Biol. 2019 Sep;38(9):933-944. doi: 10.1089/dna.2019.4780. Epub 2019 Jul 30.
4
miR-155 in the progression of lung fibrosis in systemic sclerosis.微小RNA-155在系统性硬化症肺纤维化进展中的作用
Arthritis Res Ther. 2016 Jul 5;18(1):155. doi: 10.1186/s13075-016-1054-6.
5
Screening and identification of biomarkers for systemic sclerosis via microarray technology.基于微阵列技术的系统性硬化症生物标志物的筛选与鉴定。
Int J Mol Med. 2019 Nov;44(5):1753-1770. doi: 10.3892/ijmm.2019.4332. Epub 2019 Sep 5.
6
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD).系统性硬化症患者的间质性肺病:基于个体化医学的系统性硬化症相关间质性肺病(SSc-ILD)预测和药物筛选模型。
Front Immunol. 2020 Sep 4;11:1990. doi: 10.3389/fimmu.2020.01990. eCollection 2020.
7
Screening and identification of potential biomarkers and therapeutic targets for systemic sclerosis-associated interstitial lung disease.系统性硬化症相关间质性肺病潜在生物标志物和治疗靶点的筛选与鉴定
Arch Rheumatol. 2021 Jun 24;36(4):548-559. doi: 10.46497/ArchRheumatol.2021.8625. eCollection 2021 Dec.
8
Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.系统性硬化症相关肺动脉高压患者的细胞免疫改变和差异表达的免疫相关基因。
Front Immunol. 2022 May 18;13:868983. doi: 10.3389/fimmu.2022.868983. eCollection 2022.
9
Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.用于识别硬化性肺病或特发性肺纤维化中的间质性肺病并预测肺功能下降的生物标志物。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):228-36.
10
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease.单细胞分析揭示了系统性硬皮病相关间质性肺病中成纤维细胞的异质性和肌成纤维细胞。
Ann Rheum Dis. 2019 Oct;78(10):1379-1387. doi: 10.1136/annrheumdis-2018-214865. Epub 2019 Aug 12.

引用本文的文献

1
Matrix metalloproteinases and their tissue inhibitors as upcoming biomarker signatures of connective tissue diseases-related interstitial lung disease: towards an earlier and accurate diagnosis.基质金属蛋白酶及其组织抑制剂作为结缔组织病相关间质性肺疾病即将出现的生物标志物特征:迈向更早、更准确的诊断
Mol Med. 2025 Feb 20;31(1):70. doi: 10.1186/s10020-025-01128-2.
2
Biological correlates of radiological features of systemic sclerosis interstitial lung disease.系统性硬化症间质性肺病放射学特征的生物学关联
ERJ Open Res. 2025 Feb 3;11(1). doi: 10.1183/23120541.00596-2024. eCollection 2025 Jan.